Status:
RECRUITING
Prostate Metabolism, Cancer Risk and Gut Microbiota
Lead Sponsor:
Turku University Hospital
Collaborating Sponsors:
University of Turku
Conditions:
Prostate Cancer
Prostate Hyperplasia
Eligibility:
MALE
18+ years
Brief Summary
This is a prospective, single center translational multiple cohort study to investigate the association of gut microbiota and prostate cancer.
Detailed Description
Prostate cancer (PCa) is a significant health care system challenge. PCa is the most common male cancer in Finland and most western countries. Interestingly, although the incidence of indolent (latent...
Eligibility Criteria
Inclusion
- Provision of signed and dated informed consent form.
- Ability and stated willingness to comply with all study procedures and availability for the duration of the study.
Exclusion
- inability to comply with study procedures or unwillingness to participate in the study.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 15 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06116851
Start Date
June 1 2022
End Date
September 15 2026
Last Update
November 3 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Turku
Turku, Finland, 20100
2
Turku University Hospital
Turku, Finland